It usually means one of four things, and the message you received probably did not say which. Your prescription may be moving to a different compounding pharmacy, to a different concentration or presentation, to an FDA-approved product, or it may be ending. Those have very different consequences for your dosing, your cost, and your next few weeks, so the useful response is not to worry but to find out which one applies.<\/p>\n
Do not change anything about how you take your current supply while you work this out. Finish what you have as prescribed unless your provider tells you otherwise.<\/p>\n
A pharmacy change.<\/strong> Your prescription moves to a different compounder. The active ingredient is the same, but concentration, fill volume, and labeling may differ, which affects how you measure a dose.<\/p>\n A concentration or format change.<\/strong> Same pharmacy, different preparation. This is the change most likely to cause a dosing error, because the number on your syringe may no longer mean what it used to.<\/p>\n A move to an approved product.<\/strong> Your provider transitions you to an FDA-approved medication. Different dose ladder, different device, usually different cost.<\/p>\n Discontinuation.<\/strong> The compounded preparation is no longer available to you and there is no direct substitute.<\/p>\n Send these in writing so you have the answers in writing.<\/p>\n Question two is the one that matters most and the one most likely to get a vague answer. Push until it is specific.<\/p>\n If your compounded medication is supplied in a vial and you draw your dose with a syringe, your dose is a volume of liquid, and the amount of medication in that volume depends entirely on the concentration of the preparation.<\/p>\n Change the concentration without changing the volume you draw and you have changed your dose. This is a documented source of harm. A case series of compounded semaglutide administration errors reported to a poison control center describes exactly this category of problem, and the FDA has separately alerted patients and prescribers to dosing errors involving compounded semaglutide, some resulting in hospitalization.<\/p>\n Consider this scenario: a patient has drawn the same mark on the same syringe every week for months. Their new shipment arrives from a different pharmacy, the vial looks similar, and they draw to the familiar mark out of habit. If the new preparation is more concentrated, they have just taken more than their prescribed dose, and nothing about the process alerted them.<\/p>\n The protection is simple. When any shipment differs from the last one in any visible way, do not draw until you have confirmed with the pharmacy what volume equals your prescribed dose for that specific preparation.<\/p>\n If there is a gap between supplies, the instinct is to make what you have last. Do not stretch doses, split doses, or skip weeks to bridge it. That is a dosing change, and it belongs to your provider.<\/p>\n If a gap is unavoidable, ask what your provider wants you to do about resuming, because returning to your previous dose after a break is not automatic. Our guide on taking a break from Ozempic and restarting<\/a> covers what that decision involves.<\/p>\n Do not mix old and new preparations, and do not keep drawing from an old vial after starting a new one with a different concentration. Keep them physically separate so there is no chance of reaching for the wrong one.<\/p>\n Ask your pharmacy what to do with anything you will not use. Needles go into a sharps container regardless.<\/p>\n If the preparing pharmacy is changing, it is reasonable to ask which one and to check it yourself. Compounded medications are not FDA-approved, which means the quality controls sit with the pharmacy rather than with a premarket review process, and that makes the pharmacy’s own standards the thing worth knowing about. Our guide on verifying that a compounding pharmacy is safe and legitimate<\/a> covers what to look for.<\/p>\n You can also ask about storage requirements for the new preparation, since these vary between compounders and are sometimes stricter than what you were following before.<\/p>\n Call, do not wait for a reply, if:<\/p>\n That fourth one is worth acting on promptly rather than waiting to see how you feel. Describe what you drew, from which vial, and what the label says.<\/p>\n A prescription change is not usually a sign that anything went wrong with your treatment or that you did something wrong. The compounding rules for GLP-1 medications have shifted considerably since the shortages that made large-scale compounding common, and providers adjusting to that is ordinary.<\/p>\n It is also not a reason to source medication elsewhere on your own. Whatever the change means, it does not make an unverified seller a reasonable alternative.<\/p>\n Find out which of the four changes this is. Confirm in writing whether your measured dose changes. Never draw from an unfamiliar preparation on habit. Do not stretch a gap yourself. And if anything about the new supply is unclear when a dose is due, call rather than guess.<\/p>\nThe six questions to ask<\/h2>\n
\n
Why concentration is the dangerous part<\/h2>\n
Do not fix a gap yourself<\/h2>\n
What to do with your old supply<\/h2>\n
Questions worth asking about the pharmacy<\/h2>\n
When to call rather than email<\/h2>\n
\n
What this is not<\/h2>\n
The short version<\/h2>\n